Resverlogix Corp.

C$0.07As of Sun 8 Nov 2026, 12:00 UTC
TSX:RVXHealthcare
Country Canada
PE (Fwd) •••
TSR 10Y CAGR (27.72%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.96
PE TTM —
TSR TTM (21.05%)
Mkt cap C$25.82M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0794
5.93%
(37.56%)
Buy 1|0|7|8|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
8.52%
10.12%
7.40%
(2.38%)
Revenue$M
1.117
1.118
1.167
1.190
1.90%
(3.12%)
2.02%
6.80%
Peers (US$18.28M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
3.098
(0.517)
(0.518)
EBIT/Intx
0.540
0.167
0.159
Own earn%
70.02
46.33
26.85
Sh yield%
15.33
16.81
16.98
Owners
Insiders/Inst%
5.12
25.06
Short interest%
1.45
SBC / revenue%
1.42
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
21–28
$1 testx
—
Incr. ROIC%
7